Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)
Patrick Schöffski, Jean-Yves Blay, Jacques De Greve, Etienne Brain, Jean-Pascal Machiels, Jean-Charles Soria, Stefan Sleijfer, Pascal Wolter, Isabelle Ray-Coquard, Christel Fontaine, Gerd Munzert, HolVolume:
46
Year:
2010
Language:
english
Pages:
2216
DOI:
10.1016/j.ejca.2010.03.039
File:
PDF, 657 KB
english, 2010